Caps the total amount that a covered person is required to pay for a covered prescription asthma inhaler to twenty-five dollars ($25.00) per thirty (30) day supply.
JOINT RESOLUTION TO AMEND THE MEDICAID SECTION 1115 DEMONSTRATION WAIVER REQUESTS AND RENEWALS (This joint resolution would approve an amendment to a Medicaid section 1115 demonstration waiver and renewals regarding a pilot proposal to reduce the number of days behaviorally complex patients spend in acute care facilities.)
Provides a special enrollment period for applicants for Medicare Part B. Also prohibits state insurance carriers from denying/imposing conditions on new enrollees or discriminate on price based upon health status/claims experience/preexisting conditions.
Requires the secretary of the executive office of health and human services to present to the general assembly a plan for the realignment of state hospitals into a department of hospitals no later than September 1, 2024.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2025.
Amends the conditions upon which a nurse would be exempt from certain licensing requirements to include eligibility to practice, before taking and receiving results of the National Council Licensure Examination (NCLEX).
Establishes Children's Catastrophic Illness in Children Relief Fund to provide finance assistance to families for medical expenses not covered by state or federal programs or insurance contract.
Increases insurance coverage for hearing aids from one thousand five hundred dollars to two thousand dollars, per ear, every three years for all people regardless of age.
Prohibits healthcare entities from interfering with a patient's right to choose to obtain a clinician-administered drug from their provider or pharmacy of choice.
Requires every individual or group health insurance contract effective on or after January 1, 2025, to provide coverage to the insured and the insured's spouse and dependents for all FDA-approved contraceptive drugs, devices and other products.